$2 million will enable preclinical dose and efficacy testing of “compound 3”
Acute symptomatic seizures detected in five of 22 patients monitored
Depressed patients also have increased odds for new brain lesions on MRI
No actionable pathology was missed in large patient series
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers hope it will lead to earlier, more accurate diagnosis
$2M NIH grant will help see if dual-action agent lengthens treatment window
Researchers pair postmortem MRI with histopathology to explore thalamic atrophy
Odds of seizure freedom diminish with each additional operation
Study compares financial impacts of clinical and geographic factors
Some of the first epidemiologic insights into brain disorders caused by de novo variants
Advertisement
Advertisement